Human LIGHT/TNFSF 14 enzyme-linked immunoassay kit

CAT: EH0356 Datasheet
Specification 96 Test
Sensitivity 0.02pg/ml (50 μl); 1.79pg/ml (10 μl);
Standard Curve Range 1.37 ~1000 pg/ml
Standard Curve Gradient 7 Points/3 Folds
Number of Incubations 2
Detectable sample Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc.
Sample Volume 50 μl/10 μl
Type Fully Ready-to-Use
Operation Duration 120min
pg/ml O.D. Average Corrected
0.00 0.0056 0.0054 0.0055
1.37 0.0182 0.0157 0.0170 0.0115
4.12 0.0454 0.0464 0.0459 0.0404
12.35 0.1327 0.1317 0.1322 0.1267
37.04 0.3915 0.3874 0.3895 0.3840
111.11 1.0448 1.1238 1.0843 1.0788
333.33 2.6482 2.7299 2.6891 2.6836
1000.00 4.4024 4.5220 4.4622 4.4567

Precision

Intra-assay Precision Inter-assay Precision
Sample Number S1 S2 S3 S1 S2 S3
22 22 22 6 6 6
Average(pg/ml) 18.2 99.3 351.5 18.2 92.8 322.2
Standard Deviation 0.6 2.5 18.2 1.1 5.8 19.2
Coefficient of Variation(%) 3.3 2.5 5.2 6.2 6.3 5.9

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery

The spike recovery was evaluated by spiking 3 levels of human LIGHT/TNFSF14 into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 80% to 99% with an overall mean recovery of 94%.

Sample Values

Sample Matrix Sample Evaluated Range (pg/ml) Detectable (%) Mean of Detectable (pg/ml)
Serum301.30-7.011003.49

Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of human LIGHT/TNFSF14 in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.

Background: LIGHT/TNFSF 14

LIGHT, also known as TNFSF14, is a homotrimeric glycoprotein in the TNF superfamily. It is expressed on the surface of activated lymphocytes, NK cells, immature dendritic cells, monocytes, and granulocytes. A soluble form can be shed by proteolysis. LIGHT binds and activates HVEM/TNFRSF14 to costimulate Th1 immune responses, enhance CD8+ T cell‑mediated tumor immunity, and regulate allogeneic T cell activation and allograft rejection. In addition, it binds and activates Lymphotoxin beta R/TNFRSF3 to induce apoptosis, cytokine production, mesenteric lymph node organogenesis, and maintenance of lymph node structure and function. It can also bind the soluble human decoy receptor DcR3/TNFRSF6B.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee